Laguna Beach, California
United States
116
2026-04-23
The entities that hold a legal rights for patent applications filed by inventor Burk Robert M.:
Robert M. Burk from Laguna Beach, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#2 | 2025-02-06COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#3 | 2024-10-31PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#4 | 2024-05-16COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#5 | 2024-05-09PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#6 | 2023-12-14COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#7 | 2023-11-09COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#8 | 2022-11-10PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#9 | 2022-10-20COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#10 | 2022-10-20Compounds and methods for the treatment of ocular disorders
#11 | 2021-04-15Compounds and methods for the treatment of ocular disorders
#12 | 2021-03-25PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#13 | 2020-10-22Compounds and methods for the treatment of ocular disorders
#14 | 2018-06-14Prostamide-containing intraocular implant
#15 | 2018-03-15Methods for fat reduction
#16 | 2017-10-19Ester prodrugs of gamma-lactams and their use
#17 | 2017-06-01Prostamides for the treatment of glaucoma and related diseases
#18 | 2017-06-01SKIN WOUND HEALING AND SCAR REDUCTION WITH PROSTAGLANDIN EP4 AGONIST COMBINATIONS
#19 | 2017-05-25COMPOUNDS AND METHODS FOR SKIN REPAIR
#20 | 2017-03-23Quaternary ammonium alkyl esters as stable prodrugs
#21 | 2017-01-1015-aryl prostaglandins as EP4 agonists, and methods of use thereof
#22 | 2016-11-03Methods for fat reduction
#23 | 2016-10-27PROSTAMIDES FOR ENHANCEMENT OF LEPTIN PRODUCTION
#24 | 2016-08-04STABLE AQUEOUS COMPOSITIONS OF PROSTGLANDIN AGONIST PRODRUGS AND METHODS FOR USE THEREOF
#25 | 2016-07-14Prostamide-containing intraocular implant
#26 | 2016-01-28Compounds and methods for treating ocular diseases
#27 | 2015-11-26Amidoalkylenyl and amidoaryl esters, compositions thereof, and methods for their use
#28 | 2015-11-12Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
#29 | 2015-10-01THERAPEUTIC LACTAMS
#30 | 2015-04-30Therapeutic cyclopentanols, compositions thereof, and methods for use thereof
#31 | 2015-04-30Phosphate Esters of Bimatoprost and the Prostamides
#32 | 2015-01-01Substituted cyclopentanes for inducing hair growth
#33 | 2014-09-18PROSTAMIDES FOR ENHANCEMENT OF LEPTIN PRODUCTION
#34 | 2014-09-18Prostamide-containing intraocular implant
#35 | 2014-08-21Combination therapy for glaucoma
#36 | 2014-06-19Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
#37 | 2014-05-22COMPOUNDS AND METHODS FOR SKIN REPAIR
#38 | 2014-05-22SKIN WOUND HEALING AND SCAR REDUCTION WITH PROSTAGLANDIN EP4 AGONIST COMBINATIONS
#39 | 2014-04-17Prostamides for the treatment of glaucoma and related diseases
#40 | 2014-02-27Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
#41 | 2013-12-05Ester Derivatives of Bimatoprost Compositions and Methods
#42 | 2013-09-19THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
#43 | 2013-01-31N,N-dialkylalkylenyl esters, compositions thereof, and methods for use thereof
#44 | 2012-11-22Ester derivatives of bimatoprost compositions and methods
#45 | 2012-07-12Substituted cyclopentanes having prostaglandin activity
#46 | 2012-06-07COMPOUNDS AND METHODS FOR SKIN REPAIR
#47 | 2012-05-31COMPOUNDS AND METHODS FOR SKIN REPAIR
#48 | 2011-12-01NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS
#49 | 2011-06-23Prostaglandins and analogues as agents for lowering intraocular pressure
#50 | 2011-06-23Combination Therapy For Glaucoma
#51 | 2011-06-09STABLE AQUEOUS COMPOSITIONS OF PROSTGLANDIN AGONIST PRODRUGS AND METHODS FOR USE THEREOF
#52 | 2011-06-02Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
#53 | 2011-04-07Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
#54 | 2010-12-16Therapeutic compounds
#55 | 2010-11-04THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
#56 | 2010-07-08Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
#57 | 2010-03-11Therapeutic compounds
#58 | 2009-12-24Therapeutic lactams
#59 | 2009-11-05Therapeutic compounds
#60 | 2009-10-01Therapeutic compounds
#61 | 2009-09-24Therapeutic compounds
#62 | 2009-09-24Therapeutic substituted cyclopentanes
#63 | 2009-09-24Therapeutic amides
#64 | 2009-09-17Therapeutic compounds
#65 | 2009-09-10Substituted cyclopentanes having prostaglandin activity
#66 | 2009-08-06Substituted cyclopentanes having prostaglandin activity
#67 | 2009-07-23Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
#68 | 2009-07-23Therapeutic beta-lactams
#69 | 2009-06-04Substituted cyclopentanes having prostaglandin activity
#70 | 2009-05-14Substituted cyclopentanes having prostaglandin activity
#71 | 2009-04-16Therapeutic lactams
#72 | 2009-03-05Therapeutic substituted piperidone compounds
#73 | 2009-01-08Therapeutic esters
#74 | 2008-12-18Therapeutic substituted cyclopentanes
#75 | 2008-07-10Sulfonamides
#76 | 2008-06-05Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
#77 | 2008-05-22Therapeutic amides
#78 | 2008-05-15Therapeutic β-lactams
#79 | 2008-02-14Prostamides for the treatment of glaucoma and related diseases
#80 | 2008-02-14Therapeutic lactams
#81 | 2007-11-15Therapeutic compounds
#82 | 2007-10-04THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
#83 | 2007-09-20ω-Cycloalkyl 17-heteroaryl prostaglandin Eanalogs as EP-receptor agonists
#84 | 2007-09-20CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-THIOCARBAMOYLOXY AND 2-CARBAMOYLOXY COMPOUNDS AS THERAPEUTIC AGENTS
#85 | 2007-09-20Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
#86 | 2007-06-21Sulfonamides
#87 | 2007-06-07Therapeutic substituted cyclopentanes
#88 | 2007-05-17NOVEL PROSTAMIDES FOR THE TREATMENT OF GLAUCOMA AND RELATED DISEASES
#89 | 2007-05-17Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
#90 | 2007-05-15Prostaglandin D2 antagonist
#91 | 2007-05-03Prostaglandins and analogues as agents for lowering intraocular pressure
#92 | 2007-03-08Prostaglandin analogs
#93 | 2007-02-22Sulfonamides
#94 | 2006-11-09Therapeutic substituted β-lactams
#95 | 2006-11-02Cyclohexyl prostaglandin analogs as EP-receptor agonists
#96 | 2006-09-28Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
#97 | 2006-09-14Therapeutic compounds
#98 | 2006-05-252,3,4-substituted cyclopentanones as therapeutic agents
#99 | 2006-05-182,3,4-substituted cyclopentanones as therapeutic agents
#100 | 2006-05-04Prostaglandin EPantagonists
68530 ⎘